Analyzes the revised company law's impact on directors' legal duties and corporate governance in China, highlighting legislative value and implications.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zhenai Jin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: